Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Loirat, D.
Right arrow Articles by Michel, M.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loirat, D.
Right arrow Articles by Michel, M.-L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 15, No. 10, pp. 1125-1136, October 2003
© 2003 Japanese Society for Immunology

HBsAg/HLA-A2 transgenic mice: a model for T cell tolerance to hepatitis B surface antigen in chronic hepatitis B virus infection

D. Loirat1,2, M. Mancini-Bourgine1, J.-P. Abastado2 and M.-L. Michel1

1 Unité de Recombinaison et Expression Génétique/INSERM U163 and Unité de Carcinogenèse Hépatique et Virologie Moléculaire/INSERM U370, Institut Pasteur, 28 rue du Dr Roux, 75 015 Paris, France 2 IDM (Immuno-Design Molecules), 172 rue de Charonne, 75011 Paris, France

Correspondence to: M.-L. Michel, Unité Institut Pasteur/INSERM U370, Carcinogenèse Hépatique et Virologie Moléculaire, Batiment Lwoff, Institut Pasteur, 28 rue du Dr Roux, 75015 Paris, France. E-mail: maloum{at}pasteur.fr
Transmitting editor: G. J. Hämmerling

A humanized murine model was developed to study T cell tolerance to the hepatitis B surface antigen (HBsAg) that is present in sera of hepatitis B virus chronic carriers. The HBsAg/HLA-A2 double-transgenic mice express a chimeric HLA-A2 MHC class I molecule and a high amount of the HBsAg in the liver that is secreted and present in sera during the animal’s lifetime. In these mice, injection of plasmid DNA encoding HBsAg induced a high frequency of CD8+ T cells secreting IFN-{gamma} in the periphery, with in vitro cytolytic activity and specificity for two dominant HBs-specific HLA-A2-restricted epitopes. Nevertheless, the DNA-based immunization elicited neither Th1 nor Th2 CD4+ T cell responses. Despite a high concentration of HBsAg in sera, these mice developed an immunocompetent CD8+ T cell repertoire towards the viral self-antigen, whereas the CD4+ T cell repertoire was tolerized. In the absence of a CD4+ T cell response, the IFN-{gamma}-secreting CD8+ T cells primed by DNA-based immunization were unable to exert their antiviral functions in vivo on liver cells expressing the transgene product. However, when pro-inflammatory stimuli were given before or after DNA-based immunization, the HBsAg was cleared from the serum. This effect was antibody dependent and associated with the detection of an HBs-specific Th1 CD4+ T cell response in the periphery. This model provides evidence that HBsAg displayed a strong tolerogenic effect on the CD4+ T cell compartment that is associated with a defect in CD8+ T cell effector functions in vivo.

Keywords: inflammation, T lymphocyte, vaccination, viral infection


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
GutHome page
A M Woltman, A Boonstra, and H L A Janssen
Dendritic cells in chronic viral hepatitis B and C: victims or guardian angels?
Gut, January 1, 2010; 59(01): 115 - 125.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L.-R. Huang, H.-L. Wu, P.-J. Chen, and D.-S. Chen
An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection
PNAS, November 21, 2006; 103(47): 17862 - 17867.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.